SHANGHAI, June 4, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently developed innovative...
U.S. Army Veteran And Public Servant Launches Service-Driven Campaign Focused On Health, Education, Opportunity, And AccountabilityST. JOHNS COUNTY, Fla., June 4, 2026 /PRNewswire/ --...
The intravenous part of the Phase IIb clinical dose-finding trial PROCEED met its primary endpoint, with bocunebart demonstrating a statistically significant reduction in monthly...
European Pension Investors Back Strategy Focused on Korea's Rapidly Expanding Rental Housing MarketNEW YORK, June 4, 2026 /PRNewswire/ -- Tishman Speyer today announced the...
Chinese model targets local issues, improves livelihoods in remote Laos settlementLUANG PRABANG, Laos, June 4, 2026 /PRNewswire/ -- A report from Chinadaily.com.cnTo mark the...
Zydus Hospitals Ahmedabad and Vadodara reach new heights in advanced transplant care AHMEDABAD, India, June 4, 2026 /PRNewswire/ -- Organ transplantation in India has come a...
KELLOGG, Idaho, June 3, 2026 /PRNewswire/ -- Sunshine Silver Mining & Refining Company (the "Company" or "Sunshine") today announced the pricing of its initial...
SHANGHAI, June 3, 2026 /PRNewswire/ -- On June 1 (Chicago time), in a Late-Breaking Abstract (LBA) oral presentation at the 2026 American Society of Clinical...
Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.
New GeneSight ® Mental Health Monitor Reveals 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
New GeneSight ® Mental Health Monitor Reveals 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
Specialty and Generic Medicines Leader Honored for Dedication to the Dermatology FieldNEW YORK, June 3, 2026 /PRNewswire/ -- On Tuesday evening at The Plaza...